Prudential Financial’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-11,172
Closed -$477K 2660
2023
Q1
$477K Sell
11,172
-200
-2% -$8.54K ﹤0.01% 2086
2022
Q4
$546K Buy
11,372
+135
+1% +$6.48K ﹤0.01% 1989
2022
Q3
$423K Buy
+11,237
New +$423K ﹤0.01% 2141